Liu 2012.

Trial name or title	Randomised, double blind, placebo control trial to evaluate the efficacy of Astragalus membranaceus in the patients after stroke with fatigue (NCT01554787)
Methods	Randomised, double‐blind, placebo‐controlled trial
Participants	Target number of participants: 90 participants who are 3 months after stroke and with a fatigue score ≥ 4 (fatigue scale not specified), aged 40 to 80 years old
Interventions	Astragalus membranaceus (Chinese herb) versus placebo
Outcomes	Measured at 2‐year follow‐up Primary outcomes: EORTC QLQ‐C30 and BFI‐T Secondary outcome: 36‐item Short Form
Starting date	January 2012
Contact information	Chung‐Hsiang Liu, China Medical University Hospital, Taichung, Taiwan. Tel. 886‐4‐22052121 ext 7635 Email: greengen@gmail.com
Notes	The estimated completion date of the study is December 2013. However, by November 2014, we identified no relevant publication for this study. We contacted the investigator via email to request for further information in November 2014 but received no reply prior to publication of this review